| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2023 | Noll A, Myers C, Biery MC, Meechan M, Tahiri S, Rajendran A, Berens ME, Paine D, Byron S, Zhang J, Winter C, Pakiam F, Leary SES, Cole BL, Jackson ER, ... ... Evans MK, et al. Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma. Neoplasia (New York, N.Y.). 43: 100921. PMID 37603953 DOI: 10.1016/j.neo.2023.100921 | 0.342 | |||
| 2023 | Evans MK, Matsui Y, Xu B, Willis C, Loome J, Milburn L, Fan Y, Pagala V, Peng JC. Author Correction: Ybx1 fine-tunes PRC2 activities to control embryonic brain development. Nature Communications. 14: 412. PMID 36697392 DOI: 10.1038/s41467-023-36069-z | 0.47 | |||
| 2021 | Langdon CG, Gadek KE, Garcia MR, Evans MK, Reed KB, Bush M, Hanna JA, Drummond CJ, Maguire MC, Leavey PJ, Finkelstein D, Jin H, Schreiner PA, Rehg JE, Hatley ME. Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity. Nature Communications. 12: 5520. PMID 34535684 DOI: 10.1038/s41467-021-25829-4 | 0.522 | |||
| 2020 | Evans MK, Matsui Y, Xu B, Willis C, Loome J, Milburn L, Fan Y, Pagala V, Peng JC. Ybx1 fine-tunes PRC2 activities to control embryonic brain development. Nature Communications. 11: 4060. PMID 32792512 DOI: 10.1038/S41467-020-17878-Y | 0.558 | |||
| 2019 | Yang X, Xu B, Mulvey B, Evans M, Jordan S, Wang YD, Pagala V, Peng J, Fan Y, Patel A, Peng JC. Differentiation of human pluripotent stem cells into neurons or cortical organoids requires transcriptional co-regulation by UTX and 53BP1. Nature Neuroscience. PMID 30718900 DOI: 10.1038/S41593-018-0328-5 | 0.539 | |||
| 2018 | Evans MK, Brown MC, Geradts J, Bao X, Robinson TJ, Jolly MK, Vermeulen P, Palmer GM, Gromeier M, Levine H, Morse MA, Van Laere S, Devi GR. XIAP regulation by MNK links MAPK and NFκB signaling to determine an aggressive breast cancer phenotype. Cancer Research. PMID 29351901 DOI: 10.1158/0008-5472.Can-17-1667 | 0.705 | |||
| 2017 | Sauer S, Evans M, Morse M, Devi G. Abstract P2-04-21: Suppression of immune response by X-linked inhibitor of apoptosis protein-nuclear factor kappa-light-chain-enhancer of activated B cells tumor cell signaling Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P2-04-21 | 0.637 | |||
| 2016 | Evans MK, Sauer SJ, Nath S, Robinson TJ, Morse MA, Devi GR. X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity. Cell Death & Disease. 7: e2073. PMID 26821068 DOI: 10.1038/Cddis.2015.412 | 0.668 | |||
| 2016 | Evans MK, Geradts J, Edwards C, Price A, Arora AJ, Aldrich AJ, Ramirez A, Robinson TJ, Vermeulen PB, Laere Sv, Devi GR. Abstract LB-015: XIAP induction by the MAPK-eIF4G1 pathway drives NFκB activation in inflammatory breast cancer growth and therapeutic resistance Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-015 | 0.678 | |||
| 2015 | Allensworth JL, Evans MK, Bertucci F, Aldrich AJ, Festa RA, Finetti P, Ueno NT, Safi R, McDonnell DP, Thiele DJ, Van Laere S, Devi GR. Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer. Molecular Oncology. 9: 1155-68. PMID 25769405 DOI: 10.1016/J.Molonc.2015.02.007 | 0.671 | |||
| 2015 | Evans MK, Sauer SJ, Aldrich AJ, Geradts J, Vermeulen P, Dirix L, Laere SV, Devi GR. Abstract P6-14-05: A novel link between anti-apoptotic signaling, NFκB, and SMAD7 in IBC pathobiology Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P6-14-05 | 0.726 | |||
| 2015 | Price A, Edwards CM, Evans MK, Devi G. Abstract 1007: Elucidating a role for the translation initiation factor, eIF4G1, in resistance to therapy in inflammatory breast cancer (IBC) Cancer Research. 75: 1007-1007. DOI: 10.1158/1538-7445.Am2015-1007 | 0.664 | |||
| 2014 | Evans MK, Tovmasyan A, Batinic-Haberle I, Devi GR. Mn porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death. Free Radical Biology & Medicine. 68: 302-14. PMID 24334253 DOI: 10.1016/J.Freeradbiomed.2013.11.031 | 0.633 | |||
| 2014 | Devi G, Allensworth J, Evans M, Ueno N, McDonnell D, Bertucci F, Van Laere S. 80 Determination of an oxidative stress gene signature in inflammatory breast cancer patient tumors and development of a novel redox modulatory strategy in overcoming chemotherapy resistance and mediating anti-tumor efficacy European Journal of Cancer. 50: 31. DOI: 10.1016/S0959-8049(14)70206-0 | 0.674 | |||
| 2014 | Devi GR, Allensworth JL, Evans MK, Sauer SJ. The Role of Oxidative Stress in Breast Cancer Cancer: Oxidative Stress and Dietary Antioxidants. 3-14. DOI: 10.1016/B978-0-12-405205-5.00001-5 | 0.547 | |||
| 2013 | Evans M, Tovmasyan A, Batinic-Haberle I, Devi G. Abstract 5552: Manganese porphyrins in combination with ascorbate act as pro-oxidants and mediate caspase-independent cancer cell death. Cancer Research. 73: 5552-5552. DOI: 10.1158/1538-7445.Am2013-5552 | 0.646 | |||
| 2007 | Evans MK, Yu CR, Lohani A, Mahdi RM, Liu X, Trzeciak AR, Egwuagu CE. Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals. Oncogene. 26: 1941-8. PMID 17001312 DOI: 10.1038/sj.onc.1209993 | 0.318 | |||
| Show low-probability matches. | |||||